Diagnostic applications of the "pattern" electroretinography and visual evoked potentials in the evaluation of disorders of visual pathway function in Parkinson's disease
Abstract
ABSTRACT
Background and Aim: In spite of continuous research efforts, specific laboratory, neuropsychological or neurophysiological tests for the diagnosis of Parkinson’s disease have not been established. The aims of the paper are to determine the impact of visual pathway disorders on “pattern” electroretinogram and visual evoked potentials in certain stages of Parkinson's disease.
Materials and Methods: The study was carried out in a group of 60 persons of both sexes, who were suffering from idiopathic Parkinson's disease at the I-IV stage of the desease according to the Hoehn and Yahr scale, and 30 healthy persons in the control group. The battery of non-invasive neurophysiological tests was used to estimate the functional status of the visual pathway: "pattern" electroretinography (PERG) and visual evoked potentials (VEP).
Results: In the early phase of PB there is a linear increase in the latency of the wave N50 of the "pattern" electroretinogram and the wave P100 of the visual evoked potentials with significant extension of the latency of the N50 and P100 waves in subsequent stages of Parkinson's disease. Diagnostic application of the "pattern" electroretinography and visual evoked potentials enables the confirmation of a disorder in the visual pathway function in Parkinson's disease.
Conclusion: These neurophysiological techniques may record early changes in the function of retinal structures and the optic nerve in PD, which might be significant both from the diagnostic and therapeutic aspects.
References
Armstrong RA. Visual symptoms in Parkinson's disease. Parkinsons Dis. 2011; 2011: 908306.
Bodis-Wollner I. Foveal vision is impaired in Parkinson's dis-ease. Parkinsonism Relat Disord 2013; 19(1): 1‒14.
Živković M, Dayanir V, Stamenović J, Ljubisavljević S, Pražić A, Zlatanović M, et al. Retinal Ganglion cell/inner plexiform layer thickness in patients with Parkinson’s disease. Folia Neuropa-thol 2017; 55(2): 168‒73.
Langheinrich T, Tebartz van Elst L, Lagrèze WA, Bach M, Lück-ing CH, Greenlee MW. Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol 2000; 111(1): 66‒74.
Garcia-Martin E, Rodriguez-Mena D, Satue M, Almarcegui C, Dolz I, Alarcia R, et al. Electrophysiology and optical coher-ence tomography to evaluate Parkinson disease severity. In-vest Ophthalmol Vis Sci 2014; 55(2): 696‒705.
Liu C, Zhang Y, Tang W, Wang B, Wang B, He S. Evoked po-tential changes in patients with Parkinson's disease. Brain Be-hav 2017; 7(5): e00703.
Hasanov S, Demirkilinc Biler E, Acarer A, Akkın C, Colakoglu Z, Uretmen O. Functional and hological assessment of ocular structures and follow-up of patients with early-stage Parkin-son's disease. Int Ophthalmol 2019; 39(6): 1255‒62.
Nowacka B, Lubiński W, Honczarenko K, Potemkowski A, Safranow K. Bioelectrical function and structural assessment of the reti-na in patients with early stages of Parkinson's disease (PD). Doc Ophthalmol 2015; 131(2): 95‒104.
He SB, Liu CY, Chen LD, Ye ZN, Zhang YP, Tang WG, et al. Meta-Analysis of Visual Evoked Potential and Parkinson's Disease. Parkinsons Dis 2018; 2018: 3201308.
Miri S, Glazman S, Mylin L, Bodis-Wollner I. A combination of retinal morphology and visual electrophysiology testing in-creases diagnostic yield in Parkinson's disease. Parkinsonism Relat Disord 2016; 22 Suppl 1: S134‒7.